These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1863745)

  • 21. Amrinone, platelets, and the balloon pump.
    MacGillivray RG; Shama DM
    J Cardiothorac Anesth; 1988 Apr; 2(2):268. PubMed ID: 17171922
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery.
    Bailey JM; Miller BE; Kanter KR; Tosone SR; Tam VK
    Anesth Analg; 1997 Feb; 84(2):294-8. PubMed ID: 9024017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience.
    Lewis KP
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):40-5. PubMed ID: 8369467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound hypoxemia during treatment of low cardiac output after cardiopulmonary bypass.
    Dennehy KC; Dupuis JY; Nathan HJ; Wynands JE
    Can J Anaesth; 1999 Jan; 46(1):56-60. PubMed ID: 10078405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inotropic support of the heart that fails to successfully wean from cardiopulmonary bypass: the Montreal Heart Institute experience.
    Hardy JF; Belisle S
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):33-9. PubMed ID: 8103681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of heart failure in cardiac surgical patients: amrinone and other pharmacologic agents.
    LeDoux D
    Prog Cardiovasc Nurs; 1990; 5(3):78-83. PubMed ID: 2267243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass.
    Hardy JF; Searle N; Roy M; Perrault J
    Can J Anaesth; 1993 Jun; 40(6):495-501. PubMed ID: 8403112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results with amrinone in perioperative low cardiac output syndrome.
    Günnicker M; Hess W
    Thorac Cardiovasc Surg; 1987 Aug; 35(4):219-25. PubMed ID: 2444004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M; Pedemonte O; Baele P; Col J
    Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans.
    Royster RL; Butterworth JF; Prielipp RC; Zaloga GP; Lawless SG; Spray BJ; Kon ND; Wallenhaupt SL; Cordell AR
    Anesth Analg; 1993 Oct; 77(4):662-72. PubMed ID: 8214647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and hemodynamic multicenter study of the effect of intravenous amrinone in the treatment of low cardiac output after valvular replacement].
    Estanove S; Lehot JJ; Bastien O; Demortière P; Bompard D; Clerc J; Flamens C
    Ann Cardiol Angeiol (Paris); 1988; 37(7):393-7. PubMed ID: 3064697
    [No Abstract]   [Full Text] [Related]  

  • 33. IV inotropic agents: dopamine, dobutamine, and amrinone.
    Budny J; Anderson-Drevs K
    Crit Care Nurse; 1990 Feb; 10(2):54-62. PubMed ID: 2357884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amrinone: contemporary management of the low cardiac output syndrome. Introduction.
    Kaplan JA
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):1. PubMed ID: 2521044
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism.
    Wolfe MW; Saad RM; Spence TH
    Chest; 1992 Jul; 102(1):274-8. PubMed ID: 1623767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amrinone therapy during emergence from cardiopulmonary bypass.
    Royster RL; Whiteley JW; Butterworth JF
    J Thorac Cardiovasc Surg; 1991 May; 101(5):942-3. PubMed ID: 2023456
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of amrinone in myocardial insufficiency following heart surgery in children].
    Wessel A; Seiffert P
    Monatsschr Kinderheilkd; 1989 Nov; 137(11):712-5. PubMed ID: 2608071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone.
    Butterworth JF; Zaloga GP; Prielipp RC; Tucker WY; Royster RL
    Chest; 1992 Jan; 101(1):174-80. PubMed ID: 1729065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of amrinone in acute severe cardiac failure.
    Heuer H; Frenking B; Gülker H
    Arzneimittelforschung; 1988 Apr; 38(4):567-70. PubMed ID: 3401270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.